$35.00
Manufacturer: Ukraine
Treatment of hypercholesterolemia
Adults, adolescents and children aged 10 years and older with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) as an adjunct to diet when diet and other non-pharmacological measures (eg, exercise, weight loss) is insufficient.
Prevention of cardiovascular disorders
Prevention of major cardiovascular events in patients estimated to be at high risk of a first event of cardiovascular event as an adjunct to correction of other risk factors.
Description
Rozuvastatin-CZ coated tablets 40 mg. №30
Composition
active substance: rosuvastatin;
1 tablet contains rosuvastatin (as rosuvastatin calcium) – 40 mg;
excipients: microcrystalline cellulose; lactose, monohydrate; calcium hydrogen phosphate dihydrate; crospovidone; magnesium stearate;
the coating mixture contains: polyvinyl alcohol, titanium dioxide (E 171), polyethylene glycol (macrogol), talc, iron oxide yellow (E 172), iron oxide red (E 172).
Medicinal form
Film-coated tablets.
The main physicochemical properties: tablets covered with a film shell, from orange-pink to pink in color, round in shape, with a biconvex surface.
Pharmacotherapeutic group
Hypolipidemic agents. HMG-CoA reductase inhibitors.
ATX code C10A A07.
Pharmacological properties
This is a remedy that corrects fat metabolism. The active ingredient selectively and competitively inhibits the HMG-CoA reductase enzyme, which catalyzes the conversion of HMG-CoA into a cholesterol precursor in the liver. Promotes an increase in the number of LDL receptors on the surface of liver cells, increasing catabolism and seizure. It also slows down the production of VLDL, thereby reducing the total content of “bad fats” in the blood.
Indications
Rozuvastatin-CZ coated tablets is prescribed:
- with homozygous hereditary hypercholesterolemia – as an addition to diet, other lipid-lowering pharmaceuticals;
- for the treatment of primary hypercholesterolemia (type IIa, including heterozygous hereditary hypercholesterolemia);
- for the treatment of mixed dyslipidemia (type IIb) – as an addition to the diet when non-pharmacological methods are ineffective;
- for the prevention of cardiovascular complications;
- to reduce the risk of developing severe cardiovascular complications in adults at high risk of developing them.
Contraindications
You can not prescribe Rozuvastatin-CZ coated tablets:
- with intolerance to the components of the drug;
- with hepatobiliary diseases in the active phase;
- with chronic kidney disease at stages 4-5 (creatinine excretion rate <30 ml / minute);
- during pregnancy / lactation, planning pregnancy;
- with pathology of muscle tissue;
- while taking cyclosporine;
- with a predisposition to myopathy, rhabdomyolysis.
Application during pregnancy and lactation
Not applicable.
Method of administration and dosage
Rozuvastatin-CZ coated tablets is taken orally whole, without chewing, with water, regardless of the meal.
The standard starting dose for the treatment of hypercholesterolemia is 5 mg or 10 mg once a day. If necessary, it is allowed to increase the dose after 4 weeks. Due to the high likelihood of side effects, increasing the dose to 40 mg should be considered only in patients with severe hypercholesterolemia, a high risk of cardiovascular complications (for example, hereditary hypercholesterolemia), when it was not possible to achieve the target values when using lower doses.
For the prevention of cardiovascular complications, 20 mg per day is indicated.
Overdose
Symptomatic therapy, control of hepatic parameters, CPK level is recommended.
Side effects:
- Blood test changes: thrombocytopenia.
- Immune disorders: allergies, including angioedema.
- Endocrine disorders: diabetes mellitus.
- Mental disorders: depression.
- Neurological disorders: headache, polyneuropathy, insomnia, dizziness, peripheral neuropathy, amnesia, nightmares.
- Respiratory disorders: shortness of breath, cough.
- Digestive Disorders: Pancreatitis, abdominal pain, nausea, constipation / diarrhea.
- Hepatobiliary disorders: jaundice, hepatitis, increased activity of liver transaminases.
- Dermatological disorders: rash, Stevens-Johnson syndrome, urticaria, pruritus.
- Musculoskeletal disorders: myalgia, rhabdomyolysis, myopathy, myositis, arthralgia, tendon rupture, immune-mediated necrotizing myopathy.
- Urinary disorders: hematuria.
- Sexual disorders: gynecomastia.
- General disorders: edema, asthenic syndrome.
Recent Reviews